Health Catalyst, Inc. — Director's Dealing 2021

Dec 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-12-07

Reporting Person: Horstmeier Paul (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-07	Common Stock	S	2082.00	$39.9688	Disposed	91035.00	Direct
2021-12-07	Common Stock	S	400.00	$40.61	Disposed	90635.00	Direct

Footnotes

F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1.

F2: Represents the weighted average sale price of the shares sold ranging from $39.46 to $40.42 per share, inclusive.

F3: Represents the weighted average sale price of the shares sold ranging from $40.58 to $40.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).